🎗️ OncologyCapsule
Rezlidhia
Olutasidenib
IDH1 inhibitor for relapsed or refractory acute myeloid leukemia with IDH1 mutation.
Form
Capsule
Uses
1
Side effects
5
Category
Oncology
01
What is Rezlidhia used for?
- Relapsed/refractory IDH1-mutated AML
02
Olutasidenib side effects
Common side effects of Olutasidenib include:
Nausea
Fatigue
Arthralgia
Leukocytosis
Elevated liver enzymes
CommonModerateLess common
03
Olutasidenib warnings & precautions
- Differentiation syndrome. Monitor and treat promptly
- QTc prolongation risk
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Rezlidhia in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.